Lithium carbonate and valproate sodium are each recommended as monotherapy for preventing relapses in patients with bipolar disorder and are sometimes used in combination. However, combination ...

In his first face-to-face interview in almost a decade the businessman spoke about his mental health, Ozempic use and ...

Lithium is one of the most widely-used medications for the treatment of bipolar disorder because it decreases suicidal thoughts - a leading cause of death in those with bipolar - and helps manage ...

She also said lithium made her feel "drunk." Lithium is typically prescribed for people with bipolar disorder, depression, or mania, according to the National Health Service. It can also be prescribed ...

Caplyta can be used alone or with lithium or valproate for bipolar depression. Caplyta is a second-generation antipsychotic. Antipsychotics are medicines for treating certain mental health conditions.

Bipolar disorder is a mental health condition marked by extreme mood swings, including mania or hypomania and depression.

Some mood stabilizers may be unsafe for fetuses, but going off them abruptly puts a parent’s mental health at risk ...

Experts have described the findings as a "concern". Lithium prescribed on its own is the recommended first treatment for bipolar disorder. But the study of more than 23,000 patients across ...

The book covers the use of lithium in all clinical areas imaginable, from bipolar disorder to depression to dementia; provides concrete recommendations in pediatric populations, geriatric populations ...

Lithium was the first mood stabilizer approved by the FDA and is still a first-line treatment option for bipolar disorder. The company has partnered to conduct a first-of-its-kind Phase 2 study of ...

2022 — A study that showed changes in the brain in those at risk of developing bipolar disorder raises new hopes about early ... Lithium May Decrease Risk of Developing Dementia Mar. 17 ...

This group of international experts in the treatment of bipolar disorder was convened in New York in December 2003. As a departure point for their discussions, it was noted that the treatment of ...